We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-2.54%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$49.4B
AUM Growth
-$1.83B
Cap. Flow
+$236M
Cap. Flow %
0.48%
Top 10 Hldgs %
23.11%
Holding
2,899
New
506
Increased
652
Reduced
806
Closed
772

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.93B
2
KVUE icon
Kenvue
KVUE
+$537M
3
HUM icon
Humana
HUM
+$477M
4
ABBV icon
AbbVie
ABBV
+$441M
5
MSFT icon
Microsoft
MSFT
+$384M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$747M
2
AAPL icon
Apple
AAPL
+$565M
3
ATVI
Activision Blizzard
ATVI
+$467M
4
MCK icon
McKesson
MCK
+$347M
5
INTC icon
Intel
INTC
+$300M

Sector Composition

Rank Sector Weight
1 Technology 19.79%
2 Healthcare 17.06%
3 Consumer Discretionary 12.96%
4 Consumer Staples 7.45%
5 Financials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DYN icon
1951
Dyne Therapeutics
DYN
$4.28B
$198K ﹤0.01%
22,052
ACCO icon
1952
Acco Brands
ACCO
$401M
$196K ﹤0.01%
34,145
-14,175
-29% -$79K
RCEL icon
1953
Avita Medical
RCEL
$142M
$196K ﹤0.01%
13,406
-12,094
-47% -$205K
MLCO icon
1954
Melco Resorts & Entertainment
MLCO
$2.19B
$196K ﹤0.01%
+19,800
New +$230K
MVST icon
1955
Microvast
MVST
$256M
$193K ﹤0.01%
+102,027
New +$218K
AUPH icon
1956
Aurinia Pharmaceuticals
AUPH
$1.92B
$190K ﹤0.01%
+24,506
New +$240K
OPLN
1957
Openlane
OPLN
$4.27B
$189K ﹤0.01%
12,700
-13,100
-51% -$202K
STOK icon
1958
Stoke Therapeutics
STOK
$1.83B
$189K ﹤0.01%
+48,001
New +$316K
TUR icon
1959
iShares MSCI Turkey ETF
TUR
$204M
$188K ﹤0.01%
4,886
-83,206
-94% -$2.91M
EHTH icon
1960
eHealth
EHTH
$43.2M
$188K ﹤0.01%
25,435
-13,588
-35% -$107K
TREE icon
1961
LendingTree
TREE
$572M
$188K ﹤0.01%
12,100
OPI
1962
DELISTED
Office Properties Income Trust
OPI
$184K ﹤0.01%
44,846
-41,154
-48% -$286K
SMSI icon
1963
Smith Micro Software
SMSI
$14M
$183K ﹤0.01%
+3,782
New +$198K
CSTE icon
1964
Caesarstone
CSTE
$71.6M
$183K ﹤0.01%
42,650
-61,916
-59% -$298K
KORE.WS
1965
CALL
DELISTED
KORE Group Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
KORE.WS
$180K ﹤0.01%
300,000
AAMC
1966
DELISTED
Altisource Asset Management Corp
AAMC
$179K ﹤0.01%
+44,081
New +$686K
SUPV
1967
Grupo Supervielle
SUPV
$842M
$179K ﹤0.01%
+80,453
New +$231K
MKFG
1968
DELISTED
Markforged Holding Corporation
MKFG
$177K ﹤0.01%
12,196
+7,726
+173% +$109K
FSRXW
1969
CALL
DELISTED
FinServ Acquisition Corp. II Warrant
FSRXW
$176K ﹤0.01%
16,696
AAC.WS
1970
CALL
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$176K ﹤0.01%
279,637
-10,568
-4% -$8.37K
TBPH icon
1971
Theravance Biopharma
TBPH
$875M
$176K ﹤0.01%
20,400
-39,412
-66% -$380K
UGP icon
1972
Ultrapar
UGP
$6.74B
$176K ﹤0.01%
+47,937
New +$183K
ALIT icon
1973
Alight
ALIT
$523M
$176K ﹤0.01%
+1,238
New +$208K
INBK icon
1974
First Internet Bancorp
INBK
$236M
$173K ﹤0.01%
+10,702
New +$202K
NNDM
1975
Nano Dimension
NNDM
$314M
$173K ﹤0.01%
+63,492
New +$184K

Similar funds

Marshall Wace's Q3 2023 Portfolio in Review

As of Q3 2023, Marshall Wace held 2,899 positions worth $49.4B, down 3.6% from $51.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Marshall Wace's Q3 2023 filing shows 506 new, 652 increased, 806 reduced and 772 closed positions. Its largest new stake was Humana: 1,014,185 shares worth $493M. The largest sale was Amazon, an estimated $747M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q3 2023 buy was Humana: 1,014,185 shares worth $493M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $1.93B increase.
  • Marshall Wace's biggest Q3 2023 reduction was Amazon, cutting an estimated $747M.
  • Marshall Wace fully exited Johnson & Johnson in Q3 2023, selling an estimated $284M.
  • Marshall Wace's ten largest holdings make up 23% of its $49.4B portfolio in Q3 2023.
  • Marshall Wace opened 506 new positions and closed 772 in Q3 2023.
  • Marshall Wace's portfolio value fell 3.6% quarter-over-quarter to $49.4B.

Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.